Jyong Biotech Ltd. filed for an IPO that could raise as much as $40 million to advance a pipeline that includes several prospects for urinary system disorders, including one that has reached the NDA ...
Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...
AIE is a unique photophysical phenomenon, and its distinctive luminescence properties have demonstrated significant potential in the biomedical field. In urinary system diseases, AIE materials, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback